EQS-News: Eckert & Ziegler Wins “Best Managed Companies Award” for the Second Time

Berlin, May 23, 2025. Eckert & Ziegler SE (ISIN DE0005659700) has once again been honored with the “Best Managed Companies Award”. The award, presented by Deloitte Private, UBS, the Frankfurter Allgemeine Zeitung and the Federation of German Industries (BDI), recognize excellently managed medium-sized companies throughout Germany. Eckert & Ziegler has now received this coveted award the second time.

The award is the result of a comprehensive, multi-stage application process in which companies are assessed for their excellence in the core areas of strategy, productivity and innovation, culture and commitment as well as finance and governance. A consistently high level of performance in all four categories is a prerequisite for selection. The final decision is made by an independent jury made up of renowned experts from business, science and the media.

“We are proud to once again receive the “Best Managed Companies Award,” says Dr. Harald Hasselmann, CEO of Eckert & Ziegler SE. " The award encourages us to continue expanding our leading position as a supplier of isotopes for nuclear medicine and measurement technology. I would like to thank our more than 1,000 employees worldwide who have contributed significantly to this success.”

“Strategic foresight and innovative strength are the key characteristics of a Best Managed Company such as Eckert & Ziegler. The award winners navigate the constantly changing market conditions with foresight, set trends in a dynamic environment, and shape the future with the necessary caution. Eckert & Ziegler demonstrates how companies in their region can make a significant contribution to development and open up new perspectives for the economy and society,” emphasizes Dr. Christine Wolter, Partner and Lead at Deloitte Private.

About Eckert & Ziegler
Eckert & Ziegler SE with more than 1.000 employees, is a leading specialist for isotope-related components in nuclear medicine and radiation therapy. The company offers a broad range of services and products for the radiopharmaceutical industry, from early development work to contract manufacturing and distribution. Eckert & Ziegler shares (ISIN DE0005659700) are listed in the TecDax index of Deutsche Börse.
Contributing to saving lives.

Contact:
Eckert & Ziegler SE
Karolin Riehle, Investor Relations
Robert-Rössle-Str. 10, 13125 Berlin, Germany
Tel.: +49 (0) 30 / 94 10 84-138
karolin.riehle@ezag.de
www.ezag.com